BioNTech SE (BNTX)
Share Price Chart
Loading data...
Performance
The chart shows the growth of $10,000 invested in BioNTech SE in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $91,220 for a total return of roughly 812.20%. All prices are adjusted for splits and dividends.
Compare to other instruments
Popular comparisons: BNTX vs. MRNA, BNTX vs. VTI
Return
BioNTech SE had a return of -14.66% year-to-date (YTD) and -21.90% in the last 12 months. Over the past 10 years, BioNTech SE had an annualized return of 89.85%, outperforming the S&P 500 benchmark which had an annualized return of 9.13%.
Period | Return | Benchmark |
---|---|---|
1 month | -6.78% | -0.66% |
Year-To-Date | -14.66% | 3.42% |
6 months | -1.38% | 5.67% |
1 year | -21.90% | -10.89% |
5 years (annualized) | 89.85% | 9.13% |
10 years (annualized) | 89.85% | 9.13% |
Monthly Returns Heatmap
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2023 | -4.53% | -9.32% | ||||||||||
2022 | -6.75% | 2.05% | 21.35% | -10.06% |
Dividend History
BioNTech SE granted a 1.65% dividend yield in the last twelve months. The annual payout for that period amounted to $2.11 per share.
Period | TTM | 2022 |
---|---|---|
Dividend | $2.11 | $2.11 |
Dividend yield | 1.65% | 1.41% |
Monthly Dividends
The table displays the monthly dividend distributions for BioNTech SE. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2023 | $0.00 | $0.00 | ||||||||||
2022 | $2.11 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below shows the maximum drawdowns of the BioNTech SE. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.
The maximum drawdown since January 2010 for the BioNTech SE is 73.17%, recorded on Oct 20, 2022. The portfolio has not recovered from it yet.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
---|---|---|---|---|---|---|
-73.17% | Aug 10, 2021 | 303 | Oct 20, 2022 | — | — | — |
-58.07% | Mar 19, 2020 | 19 | Apr 15, 2020 | 68 | Jul 22, 2020 | 87 |
-44.5% | Jul 23, 2020 | 29 | Sep 1, 2020 | 48 | Nov 9, 2020 | 77 |
-37.07% | Dec 11, 2020 | 14 | Dec 31, 2020 | 69 | Apr 13, 2021 | 83 |
-36.7% | Jan 9, 2020 | 44 | Mar 12, 2020 | 3 | Mar 17, 2020 | 47 |
-22.91% | Nov 11, 2020 | 5 | Nov 17, 2020 | 8 | Nov 30, 2020 | 13 |
-20.51% | Dec 18, 2019 | 2 | Dec 19, 2019 | 8 | Jan 2, 2020 | 10 |
-20.25% | Oct 23, 2019 | 4 | Oct 28, 2019 | 19 | Nov 22, 2019 | 23 |
-19.58% | May 4, 2021 | 3 | May 6, 2021 | 18 | Jun 2, 2021 | 21 |
-15.59% | Jun 10, 2021 | 5 | Jun 16, 2021 | 22 | Jul 19, 2021 | 27 |
Volatility Chart
Current BioNTech SE volatility is 26.10%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.